This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Specgx LLC. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovative Mind of Thomas A. Diezi
Introduction
Thomas A. Diezi, an accomplished inventor based in Webster Groves, Missouri, has made significant contributions to the field of pharmaceuticals. With a focus on improving drug delivery and safety, Diezi stands out as a figure of innovation in the pharmaceutical industry.
Latest Patents
Thomas holds a patent for "Immediate release, abuse deterrent pharmaceutical compositions." This invention entails pharmaceutical compositions and processes designed to create solid dosage forms that not only provide immediate release of active ingredients but also possess abuse deterrent properties. The compositions feature a combination of at least one pharmaceutically active ingredient, low molecular weight hydrophilic polymers, high molecular weight hydrophilic polymers, and an effervescent system, highlighting Diezi's commitment to enhancing drug safety.
Career Highlights
Diezi is currently associated with Specgx LLC, where he applies his expertise to develop innovative pharmaceutical solutions. His work emphasizes not just the effectiveness of drug formulations but also their safety in preventing misuse, a critical aspect in today’s pharmaceutical landscape.
Collaborations
Throughout his career, Thomas has collaborated with talented individuals such as Siva N. Raman and Jae Han Park. These partnerships have likely contributed to the success and advancement of his innovative projects, showcasing the importance of teamwork in the field of invention.
Conclusion
In summary, Thomas A. Diezi is a forward-thinking inventor whose work in developing immediate release and abuse deterrent pharmaceutical compositions is paving the way for safer therapeutic options. His ongoing contributions through Specgx LLC and collaborative efforts illustrate the pivotal role he plays in advancing pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile